nad has been researched along with Kidney Diseases in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (40.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 4 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benigni, A; Brizi, V; Buttò, S; Conti, S; Corna, D; Imberti, B; Morigi, M; Perico, L; Pezzotta, A; Remuzzi, G; Sangalli, F; Tomasoni, S; Trionfini, P; Xinaris, C; Zanchi, C; Zoja, C | 1 |
| Mercado, A; Noriega, LG; Tovar-Palacio, C | 1 |
| Ban, J; Chen, S; Chen, X; Jia, Z; Li, Z; Niu, S; Pan, X; Ren, Q; Yue, L; Zhen, R; Zhu, R | 1 |
| Chapman, A; Elshani, M; Harrison, DJ; Kudsy, M; Leung, S; Reynolds, PA; Um, IH | 1 |
| Argani, H; Ashrafi Jigheh, Z; Dastmalchi, S; Ghorbani Haghjo, A; Mesgari-Abbasi, M; Nazari Soltan Ahmad, S; Panah, F; Rashtchizadeh, N; Roshangar, L; Sanajou, D | 1 |
| Camara, AKS; la Cour, MF; Medhora, M; Mehrvar, S; Ranji, M | 1 |
| Czechowska, G; Dudka, J; Korolczuk, A; Maciejewski, M; Smolen, A; Widelska, I | 1 |
| Hasegawa, K; Itoh, H; Wakino, S | 1 |
| Hershberger, KA; Hirschey, MD; Martin, AS | 1 |
| KAWAKAMI, Y; MURAMATSU, N; NAKAGAWA, Y; SAITO, E; TAKAHASHI, T | 1 |
| Hook, JB; Smith, JH | 1 |
| Haas, M; Harris, HW; Hwang, SJ; Kashgarian, M; Otuechere, G; Silva, P; Sullivan, MR; Yalla, S; Zeidel, ML | 1 |
| Bruining, HA; Coremans, JM; Naus, DC; Puppels, GJ; Van Aken, M; Van Velthuysen, ML | 1 |
| Mishnev, OD; Serdobintseva, TS; Shchegolev, AI; Tin'kova, IO | 1 |
| Bannister, DW; Evans, AJ; Whitehead, CC | 1 |
| Dolhofer, R; Wieland, OH | 1 |
| Fisher, V; Watts, RW | 1 |
| Gancevici, G | 1 |
| Lazarus, HM | 1 |
| Bauer, U; Cueni, LB; Rutishauser, G; Schoenenberger, GA | 1 |
3 review(s) available for nad and Kidney Diseases
| Article | Year |
|---|---|
Potential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease.
Topics: Humans; Kidney; Kidney Diseases; NAD; Polyphenols; Sirtuin 1 | 2022 |
Sirtuin and metabolic kidney disease.
Topics: Animals; Drug Design; Enzyme Activation; Enzyme Activators; Humans; Kidney; Kidney Diseases; Molecular Targeted Therapy; NAD; Signal Transduction; Sirtuins | 2015 |
Role of NAD
Topics: Animals; Disease Models, Animal; Heart; Heart Diseases; Humans; Kidney; Kidney Diseases; Mitochondria; NAD; Oxidation-Reduction; Signal Transduction; Sirtuins | 2017 |
17 other study(ies) available for nad and Kidney Diseases
| Article | Year |
|---|---|
Post-translational modifications by SIRT3 de-2-hydroxyisobutyrylase activity regulate glycolysis and enable nephrogenesis.
Topics: Animals; Cell Differentiation; Cell Nucleus; Chromatin; Epigenesis, Genetic; Glycolysis; Kidney; Kidney Diseases; Lysine; Mice; Mice, Inbred C57BL; NAD; Nephrons; Organogenesis; Phosphofructokinases; Protein Processing, Post-Translational; Sirtuin 3 | 2021 |
Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice.
Topics: Adenosine; Animals; Insulin Resistance; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Obese; NAD; Obesity | 2022 |
Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage.
Topics: Gene Expression Regulation; Humans; Kidney; Kidney Diseases; Kidney Glomerulus; NAD; NF-E2-Related Factor 1; Podocytes | 2023 |
Dunnione protects against experimental cisplatin-induced nephrotoxicity by modulating NQO1 and NAD
Topics: Animals; Antineoplastic Agents; Apoptosis; Cisplatin; Gene Expression Regulation; Inflammation; Kidney Diseases; NAD; NAD(P)H Dehydrogenase (Quinone); Naphthoquinones; Oxidative Stress; Protective Agents; Rats; Rats, Wistar | 2018 |
Optical Metabolic Imaging for Assessment of Radiation-Induced Injury to Rat Kidney and Mitigation by Lisinopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Female; Flavin-Adenine Dinucleotide; Gamma Rays; Imaging, Three-Dimensional; Kidney; Kidney Diseases; Lisinopril; Mitochondria; NAD; Radiation Injuries; Rats | 2019 |
The role of peroxisome-proliferator-activating receptor gamma agonists: rosiglitazone and 15-deoxy-delta12,14-prostaglandin J2 in chronic experimental cyclosporine A-induced nephrotoxicity.
Topics: Animals; Creatinine; Cyclosporine; Disease Models, Animal; Glutathione; Glutathione Disulfide; Kidney; Kidney Diseases; Male; NAD; NADP; PPAR gamma; Prostaglandin D2; Protective Agents; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Urea; Uric Acid | 2014 |
[CLINICAL USE OF DPN (DIPHOSPHOPYRIDINE NUCLEOTIDE)].
Topics: Diabetes Mellitus; Headache; Humans; Kidney Diseases; Liver Diseases; NAD; Nausea; Tachycardia; Vomiting | 1963 |
Mechanism of chloroform nephrotoxicity. III. Renal and hepatic microsomal metabolism of chloroform in mice.
Topics: Animals; Binding Sites; Biotransformation; Chloroform; Cytochrome P-450 Enzyme System; Female; In Vitro Techniques; Kidney Cortex; Kidney Diseases; Male; Mice; Mice, Inbred ICR; Microsomes; Microsomes, Liver; Mixed Function Oxygenases; NAD; NADP | 1984 |
Transport defects of rabbit medullary thick ascending limb cells in obstructive nephropathy.
Topics: Animals; Biological Transport, Active; Bumetanide; Carrier Proteins; Cell Membrane; Furosemide; Kidney Diseases; Kidney Medulla; Kinetics; NAD; Ouabain; Oxygen Consumption; Rabbits; Reference Values; Sodium; Sodium-Potassium-Chloride Symporters; Sodium-Potassium-Exchanging ATPase; Ureteral Obstruction | 1993 |
Pretransplantation assessment of renal viability with NADH fluorimetry.
Topics: Animals; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Fluorometry; Graft Rejection; Graft Survival; Ischemia; Kidney; Kidney Diseases; Kidney Transplantation; Kinetics; Male; Mitochondria; NAD; Nephrectomy; Oxidation-Reduction; Predictive Value of Tests; Rats; Rats, Inbred Strains | 2000 |
Structural and metabolic characteristic of nephrocytes during peritonitis of various genesis.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Kidney; Kidney Diseases; L-Lactate Dehydrogenase; Male; Middle Aged; NAD; NADP; Nephrons; Oxidoreductases; Peritonitis; Succinate Dehydrogenase | 2001 |
Evidence for a lesion in carbohydrate metabolism in fatty liver and kidney syndrome in chicks.
Topics: Alanine; Animals; Biotin; Carbohydrate Metabolism; Chickens; Fatty Liver; Fructosephosphates; Gluconeogenesis; Glucose; Glucosephosphates; Glutamates; Glycerophosphates; In Vitro Techniques; Ketoglutaric Acids; Kidney; Kidney Diseases; Liver; Liver Glycogen; NAD; Poultry Diseases; Pyruvates; Succinates | 1975 |
Enzymatic assay of myo-inositol in serum.
Topics: Adult; Aged; Aged, 80 and over; Chromatography, Gas; Female; Humans; Inositol; Kidney Diseases; Male; Middle Aged; NAD; Oxidation-Reduction | 1987 |
The metabolism of glyoxylate in blood from normal subjects and patients with primary hyperoxaluria.
Topics: Adolescent; Adult; Carbohydrate Metabolism, Inborn Errors; Carbon Isotopes; Child; Coenzymes; Dialysis; Erythrocytes; Female; Flavin-Adenine Dinucleotide; Freezing; Glyoxylates; Humans; In Vitro Techniques; Kidney Diseases; Leukocytes; Male; Methods; NAD; Oxalates; Oxidation-Reduction; Ultrasonics | 1968 |
Microstructure of "lypochondria" from cultured cells.
Topics: Adipose Tissue; Amnion; Animals; Carcinoma, Squamous Cell; Coloring Agents; Culture Techniques; Cytoplasm; Fatty Liver; Haplorhini; HeLa Cells; Histocytochemistry; Humans; Kidney; Kidney Diseases; Laryngeal Neoplasms; Lipids; Mice; Microscopy, Phase-Contrast; NAD; Onium Compounds; Oxazines; Oxidoreductases; Staining and Labeling | 1966 |
Isolation of cell nuclei from ischemic renal tissue: biochemical characteristics of these nuclei.
Topics: Ammonium Sulfate; Animals; Cell Aggregation; Cell Nucleus; Centrifugation; DNA; DNA Nucleotidyltransferases; Ischemia; Kidney; Kidney Diseases; Male; Manganese; Mice; Microscopy, Electron; NAD; Proteins; RNA; RNA Nucleotidyltransferases | 1972 |
Urinary lactic dehydrogenase activity. Posture dependent activity changes for the diagnosis of unilateral nephroptosis.
Topics: Humans; Kidney Diseases; L-Lactate Dehydrogenase; NAD; Oxidation-Reduction; Posture; Time Factors | 1972 |